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Abstract 
 
Diabetes and its ramifications and treatments are presented, followed by 
discussion of the importance of communication between patient and 
clinician.  Improved communication approaches, including telephone 
consultations, blood glucose communications to a provider with feedback, 
and active electronic diaries on smartphones for both type 1 and type 2 
diabetes mellitus, are reviewed. 
 
 
What Exactly Is Diabetes? 
Diabetes is a metabolic disease: a disorder of how the body uses food.  Most of 
the food eaten is digested into glucose, which enters into the bloodstream, where cells use 
it for growth and energy. Insulin, a hormone produced by the pancreas, must be present 
for glucose to be absorbed into cells. Normally, when people eat, the pancreas produces 
the proper amount of insulin necessary for glucose to be moved from the blood stream 
into the cells. In individuals with diabetes the pancreas produces either insufficient or no 
insulin, or the body’s cells do not respond correctly to the insulin which is produced. The 
net result: the body loses its fuel source even though the bloodstream contains more than 
sufficient glucose. 
Three types of diabetes mellitus exist: (1) type 1 diabetes (formerly called 
juvenile diabetes); (2) type 2 diabetes (formerly called adult onset diabetes); and (3) 
gestational diabetes.  Type 1 diabetes accounts for about 5-10% of diagnosed diabetes in 
the U.S. and occurs mostly in children and young adults but can appear at any age 
(“Types of Diabetes”, 2012).  It occurs because the body’s immune system attacks and 
destroys the insulin-producing cells in the pancreas. If not diagnosed and treated with 
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insulin, an individual with type 1 diabetes can lapse into a life-threatening coma, called 
diabetic ketoacidosis.  Most people who develop type 1 are otherwise healthy (Kasper et 
al., 2005).   
About 90-95% of diabetics have type 2 diabetes, which is most often associated 
with older age, obesity, family history of diabetes, previous history of gestational 
diabetes, physical inactivity, and certain ethnicities. About 80% of people with type 2 
diabetes are overweight or obese.  In 2010, type 2 diabetes was diagnosed in more than 
25.8 million adults over the age of 20 in the U.S., while another 7.1 million went 
undiagnosed; 81.5 million had prediabetes (Roger et al., 2011). The prevalence of type 2 
diabetes in all age, gender and ethnic groups in the U.S. is expected to more than double 
(from a prevalence of 5.6% to a prevalence of 12%) between 2005 and 2050 (Narayan et 
al., 2006).   
Type 2 diabetes is increasingly being diagnosed in children and adolescent. When 
type 2 diabetes is diagnosed, the pancreas is usually producing sufficient insulin, but for 
unknown reasons the insulin cannot be used effectively by the body and eventually a 
decrease in insulin production occurs. The result is the same as for type 1 diabetes: 
glucose increases in the blood and the body cannot use of its main source of fuel 
efficiently.  Clearly, type 2 diabetes is a significant and growing medical problem in the 
U.S. 
Some women develop gestational diabetes during pregnancy. Although 
gestational diabetes usually disappears postpartum, women who have had it have a 40-
60% likelihood of developing type 2 diabetes within 5 to 10 years. Maintaining a 
   
 
4 
 
reasonable body weight and being physically active may help prevent development of 
type 2 diabetes. 
Whatever the type, diabetes is associated with multiple long-term complications 
affecting virtually all parts of the body. The disease often leads to blindness, heart and 
blood vessel disease, stroke, kidney failure, amputations, and nerve damage (American 
Diabetes Association, 2010). Uncontrolled diabetes can complicate pregnancy, and birth 
defects are more common in babies born to women with diabetes.  Before the discovery 
of insulin in 1921, a diagnosis of type 1 diabetes was a death sentence – all patients died 
within a few years after diagnosis. Insulin, while not a cure, was the first major 
breakthrough in the treatment of diabetes. 
Basic therapies for type 1 diabetes include healthy eating, physical activity, and 
taking insulin; basic treatment for type 2 diabetes are the same as for type 1, except that 
oral medication may be substituted for insulin.  Blood glucose levels should be closely 
monitored through frequent blood glucose checking; patients with diabetes should also 
monitor blood glucose levels several times a year with a laboratory test called the HbA1c, 
results of which reflect average blood glucose levels over a 2-3 month period.  This entire 
monitoring procedure has been characterized by many diabetics as complex (Kouris et 
al., 2010) 
People with diabetes should see a health care provider who will help them learn to 
manage their diabetes and who will monitor and assist in their diabetes control. Most 
people with diabetes receive care from primary care physicians—internists, family 
practitioners, or pediatricians but occasionally a team of providers is necessary to manage 
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diabetes care successfully. The goal of diabetes management is to keep levels of blood 
glucose, blood pressure, and cholesterol as close to the normal range as safely possible.  
People with diabetes must take responsibility for their day-to-day care, much of 
which involves keeping blood glucose levels from going too low or too high. When blood 
glucose levels drop too low a person can become nervous, shaky, and confused. 
Judgment can be impaired, and if blood glucose falls too low, fainting can occur.  A 
person can also become ill if blood glucose levels rise too high. 
Uses of Communication Technologies in Diabetes 
The healthcare industry is slowly adopting new strategies to deal with the 
swelling prevalence of chronic disease, including diabetes, due largely to market 
dynamics.  Healthcare organizations constrained by revenues and less than adequate tools 
to manage chronic care patients systematically are changing from being centered on the 
provider to more centered on the patient.  Unfortunately, traditional forms of patient 
communication have not been particularly effective in improving patient adherence to 
lifestyle and medical lifestyle changes (Boland, 2006). However a host of new 
communication and remote monitoring technologies are becoming available so that 
providers can interact with patients virtually “anywhere, anytime” (Boland, 2007). 
Health authorities seem to have high expectations for telemedicine (Brown, et al., 
2007; Franc et al, 2011), which addresses several major challenges: improved access to 
healthcare (especially for patients in remote or underserved areas); assistance in 
overcoming the scarcity of qualified clinicians in the face of a diabetes epidemic; and the 
reduction of costs while improving (or, at least, maintaining) quality. The aims of 
telemedicine in the field of diabetes differ according to the type of diabetes. In type 1 
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diabetes which is associated with relatively complex insulin regimens, the goal of 
telemedicine is to assist patients in achieving better blood glucose control via more 
accurate adjustment of insulin doses. In type 2 diabetes there are two basic goals of 
telemedicine: (1) accurate and timely adjustment of insulin dosage and (2) improvement 
in blood glucose control by means of dietary and/or physical activity changes. Currently, 
there appear to be two promising approaches (Franc et al, 2011): 
(1) hand-held communication devices, especially smartphones, have been shown to improve 
blood glucose control. These systems can provide immediate patient assistance (e. g., 
insulin-dose calculation for specific meals and/or food choices), and all data stored in the 
device can be transmitted to authorized caregivers, enabling remote monitoring and even 
teleconsultation. Although these systems were initially developed for type 1 diabetes, 
they also appear to offer many possibilities for type 2 diabetes as well.  
(2) systems combining an interactive Internet system (or a mobile phone coupled to a remote 
server) with a system of communication between the patient and the healthcare provider 
(e.g., by e-mail, texting or telephone calls) have also been demonstrated to be beneficial 
for blood glucose control. Primarily aimed at patients with type 2 diabetes, these systems 
generally provide patient motivational support as well.  
Type 1 Diabetes Studies 
Telephone Consultations 
 
Several studies (Ładyzynski and Wójcicki, 2007; Lehmkuhl et al., 2010) reported 
on use of traditional (i.e., landline) telephone contacts to better manage type 1 diabetes.  
Despite somewhat different protocols, both reported that both experimental and control 
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groups demonstrated decreased mean HbA1c levels at the program, but neither group’s 
decrease was statistically significant. 
Another study (Thompson, Kozak, and Sheps, 1999) did yield significant results.  
Regular telephone contacts were proposed for patients with poorly controlled type 1 
diabetes (HbA1c > 8.5%). Patients in the experimental group had 15 minute telephone 
contacts three times a week. After 6 months, the mean HbA1c in this group had 
decreased from 9.6% to 7.8% while in the standard-care control group, the decrease in 
mean HbA1c was from 9.4% to only 8.9%. This difference in mean improvement in 
HbA1c levels between the two groups was statistically significant (P < 0.01) and 
clinically relevant, and therefore the system was considered effective, as (the researchers 
noted) would any system involving close management of diabetic patients.  However, 
patient follow-up was expensive: nurses spent an average of 17.25 hours per week calling 
patients, the equivalent of an almost half-time employee to cover 23 patients.   
Mobile telephone communications allow interaction with individuals more 
frequently and while those individuals’ behavior is actually occurring, making potential 
interventions more effective (Hitman, 2011; Riley et al., 2011).   As of December 2011, 
there were over 331.6 million wireless telephone subscribers in the US, a 39% increase in 
5 years (CITA  Advocacy, 2012), and an estimated 78% worldwide owned cell phones in 
2010, the latest data available (Sanou, 2011).  The vast use of cellular phones should 
make this type of communication system a very viable option (Brown, et al., 2007), as 
cellular phones have been demonstrated to be especially suited for engaging the self-care 
of patients  while leveraging providers’ the expertise and time (Boland, 2006, 2007).  
Measurable improvements, however, have not been demonstrated. 
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The combination of a glucose meter combined with the battery pack of a cell 
phone to make the determination of blood glucose easier has been reported (Carroll, 
Marrero and Downs, 2007; Malasanos, 2008).   Although this approach sounds 
promising, significant improvements in blood glucose control using it have not been 
demonstrated (Carroll et al., 2011). 
Blood Glucose Data Transmission to a Provider with Feedback 
 
Numerous studies have been published using different systems to transmit blood 
glucose data. These may be subdivided into three categories. The first consists of simple 
teletransmission of blood glucose values from a glucose meter with a memory function. 
Many such studies have been published, most sponsored by firms that market blood 
glucose meters.  In one study (Montori et al., 2004), patients with type 1 diabetes who 
were poorly controlled despite receiving intensive insulin therapy sent their blood 
glucose data to the care team regularly over a 6-month period using a modem. The 
experimental group received telephone “feedback” from a nurse within 24 hours of each 
transmission, and these patients’ mean HbA1c levels decreased significantly (p = 0.03).  
Reduction in mean HbA1c in the control group did occur, but was thought to be 
potentially related to a possible study effect. In another study, patients with type 1 
diabetes and poorly controlled blood sugar transmitted their data regularly by telephone 
from a glucose meter (Jansà et al., 2004).  After 6 months, both the experimental and 
control groups results were similar, but the experimental group’s costs were considerably 
higher than those of the control group.   
Nevertheless, more sophisticated systems have been developed. For example, in 
the Telematic Management of Insulin-Dependent Diabetes Mellitus (T-IDDM) project, 
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patients were provided with desktop computers, allowing them to send data in addition to 
blood glucose values.  Unfortunately, the preliminary results did not demonstrate 
significant changes in HbA1c (Bellazzi et al., 2002; d’Annunzio et al., 2003).   
Overall, the results of transmission of blood glucose values with retrospective 
feedback have been disappointing, regardless of the technology employed.  One meta-
analysis (Montori et al., 2004) included 7 randomized trials of type 1 diabetic adults 
showed statistically significant, but very limited (0.4%), improvement in HbA1c in the 
telemedicine group compared with controls, but this improvement was obtained only 
after one of the seven studies examined was excluded. These systems generally failed to 
incorporate truly effective feedback from the caregiver other than an increase in 
frequency of telephone contact with the patients, which is infeasible in routine practice in 
the long term.  As a number of other studies (Lawson, 2005; Nunn, 2006; MacLean et al., 
2012) have also failed to demonstrate a significant difference in HbA1c levels between 
experimental and control groups when telephone coaching alone was used, it appears safe 
to conclude that this approach is not particularly useful or cost-effective. 
Active Electronic Diaries on Smartphones 
There is a growing interest in self-management of diabetes via mobile health 
applications.  Chomutare et al. (2011) found 60 diabetes applications for iPhones; within 
a year and a half, the number had increased to 260 (over a 40% increase).  Other mobile 
platforms reflect a similar trend. 
Complex systems can transmit data such as insulin intake, blood glucose, dietary 
consumption, and physical activity in a readily available format for the clinician, 
allowing more rapid help for patients in determining their appropriate insulin dose 
   
 
10 
 
(Kouris et al., 2010).  A secure website coupled with a smartphone can easily do this 
(Gammon et al., 2005; Rossi et al., 2009), and is probably more attractive (as well as 
more prompt and accurate) than the traditional paper diary for patients with diabetes. 
Such a system has no autonomy or responsibility, but merely puts the data into an 
electronic format, with the insulin prescription remaining the physician’s sole 
responsibility.  A number of researchers (Rami et al., 2006; Benhamou et al., 2007; 
Istepanian et al., 2009) have demonstrated that mobile communication tools can 
potentially enhance the cost effective self-management of diabetes and improve  HbA1c 
levels. 
Several such systems are under development.  One, the “Diabetes Interactive 
Diary” (DID) (Rossi et al, 2009) meets the above description, and also features an 
electronic illustrated food list, which allows patients to simply select the quantities and 
types of foods they intend to eat, and the software automatically calculates the equivalent 
amount of carbohydrates and insulin required (Rossi et al., 2011).  Unfortunately, a 
weakness of the DID system is poor interaction with the doctor via text messages.  Also, 
results have been mixed.  Rossi et al. (2010) found little difference between control and 
experimental groups, with no significant difference in terms of decreased HbA1c levels 
(p = 0.68).   
Another system is the Diabeo system, which also incorporates the features 
previously discussed using a Personal Digital Assistant, but adds insulin doses for both 
basal and prandial blood glucose, and also for patients whose blood glucose falls 
regularly outside a predetermined range (“Multi-Technology Solutions”, 2012).  
Evaluations of the Diabeo system (Franc et al., 2009) showed good results for mean 
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blood glucose values, which were quite similar pre- and post-meals. Excellent patient 
satisfaction was observed, with a large majority expressing the wish to continue using the 
system even at their own expense, rather than continuing to use a traditional passive 
glycemic diary.  A 6-month multicenter randomized study using 80 adults with poorly 
controlled type 1 diabetes clearly showed marked metabolic improvement with the 
Diabeo system (Charpentier et al., 2011), and a follow-up study involving 700 patients 
and 100 healthcare professionals is planned for 2012 in France, where it will be the 
largest telemedicine study ever conducted in that country (“Clinical Results”, 2012).   
Type 2 Diabetes Studies 
As the prevalence of type 2 diabetes far exceeds that of type 1 diabetes, studies 
involving telemedicine for these patients have been done on a somewhat larger-scale.  In 
addition to the studies previously described for type 1 diabetes which also used apply to 
type 2 diabetes, studies designed to inform and deliver an educational message to patients 
at a lower cost also exist.  These systems generally allow patients to transmit a variety of 
additional useful data, in addition to blood glucose and HbA1c values, for diabetes 
management.  Literature is reviewed using the following typology: Internet-based blood 
glucose control systems, systems using a cellphone connected to a remote server, and 
active electronic diaries on smartphones. 
Telephone Consultations 
Early studies (Weinberger et al., 1995; Aubert et al., 1998) showed nurses’ 
telephone follow-up of diabetic patients improved patients’ blood glucose. However, 
these early interventions proved expensive and time-consuming. Telephone interventions 
using a call center manned by non-medical staff have also been tested. One such study 
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was conducted in England.  Using a call center to monitor a large population of type 2 
diabetes patients with limited resources (Young et al., 2005) yielded a 0.31% reduction in 
HbA1c in the intervention group compared with the control group (P = 0.003). 
Other studies generally support the earlier findings.  A 2000 study (Piette et al., 
2000) involving 280 English- or Spanish-speaking adults with diabetes who were treated 
in a county health care system found that blood glucose levels were significantly (P = 
0.002) lower among intervention patients than patients receiving traditional care; a 2001 
study by Piette et al. (2001) of 272 diabetic VA patients, found that an intervention by 
telephone nurses resulted in a statistically significant (P = 0.04) reduction of HbA1c at 
one year.  More recently, (Walker et al., 2011) conducted a study involving a low-income 
insured minority population with type 2 diabetes and poor blood glucose control.  They 
showed modest results of a telephone compared to a printed intervention, with a small but 
statistically improvement in HbA1c (p = 0.009) between the two groups at 1 year.   
Unfortunately, the above results are not always seen.  Krein et al. (2004) 
conducted a randomized controlled trial at two VA Medical Centers involving 246 
veterans with poorly controlled diabetes.  Two nurse practitioner case managers worked 
with patients and their primary care providers, monitoring and coordinating care for the 
intervention group through the use of telephone contacts, collaborative goal setting, and 
treatment algorithms. Control patients received educational materials and usual care from 
their primary care providers.  After 18 months, the difference in HbA1c levels between 
the experimental and control groups was not statistically significant (P = 0.65), although 
the intervention patients were substantially more satisfied with their diabetes care. 
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The combination of a glucose meter combined with the battery pack of a cell 
phone for the determination of blood glucose for type 1 diabetes was discussed earlier, 
and negative results were noted (Carroll et al., 2011).  Interestingly, when this same 
approach was used for patients with type 2 diabetics, statistically significant (P = 0.01) 
improvements in blood glucose were observed (Cho et al., 2009).  There are now 3 such 
Smartphone apps available on the market (Lieberman, 2012). 
These results, based upon quite different population types, suggest that a simple 
inexpensive telephone intervention by non-clinical health educators can be useful.  
Blood Glucose Data Transmission with Feedback from a Provider 
Internet-Based Blood Glucose Control Systems 
The use of computers by the public continues to increase, and many patients use 
this medium to find information about healthcare (Noh et al., 2010).  The most frequently 
used technology in diabetes management is the Internet, which has been shown to 
increase patients’ knowledge, support their engagement with treatment, increase patients’ 
self-efficacy, and facilitate behavior change (Brown, Lustria, and Rankins, 2007).  
Some approaches have been aimed at indirect control of blood glucose levels; 
e.g., through weight reduction or increased physical activity. An Internet-based 
supplement to traditional diabetes care used the remote intervention of coach in an 
attempt to increase patients’ physical activity. This system was evaluated in 78 sedentary 
type 2 diabetes patients over 8 weeks. A moderate increase in physical activity was found 
in the experimental group as opposed to the control group, but the lack of objective 
measures of blood glucose or HbA1c made evaluation of the true effectiveness of this 
approach impossible (McKay et al., 2001).  Examining effects of diet, Tate, Jackvony, 
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and Wing (2003) showed that Internet-based behavioral counseling significantly (P = 
0.04) improved weight loss in overweight and obese adults at risk of type 2 diabetes.  
Patients received weekly counseling and feedback via e-mail after submitting calorie and 
exercise information.  Unfortunately, as with the McKay et al. (2001) study, objective 
measures of improvement of type 2 diabetes were not reported. 
Systems Using a Cell Phone with a Remote Server 
 The ubiquitous spread of cellphones among the US population has already been 
discussed.  Krishna and Boren (2008), in a review of the literature, found that 9 out of 10 
studies that examined the use of a cell phone for health information for persons with 
diabetes or obesity reported significant improvement in HbA1c levels of experimental 
groups.  Quinn et al. (2008), in a small study (30 patients), found that patients receiving 
real-time cellphone feedback regarding blood glucose levels analyzed by WellDoc 
proprietary software had significantly decreased (P < 0.02) decreased HbA1c levels 
compared with patients not receiving such feedback.  In a study involving cell phone use 
and the internet for overweight patients with type 2 diabetes, Yoo et al. (2009) found 
statistically significant reduction of HbA1c in their experimental group, but as the study 
was short (only 12 weeks), it could not be determined if the effects observed were long-
term ones or not.  The combination of mobile behavioral coaching and lifestyle behavior, 
blood glucose data, and patient self-management data individually analyzed and 
presented with evidence-based guidelines to providers significantly (P = 0.001) reduced 
HbA1c levels over 1 year (Quinn et al 2011).  
Other systems have been tested using dedicated computers allowing patients to 
transmit more complex data from their homes.  The Informatics for Diabetes Education 
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and Telemedicine (IDEATel) study (Shea, 2007; Shea et al., 2009) was a large (1665 
participants) randomized trial involving older, ethnically diverse, medically underserved, 
Medicare beneficiaries with type 2 diabetes.  Participants in the intervention group 
received a computer with Internet access via modem to an existing telephone line and 
videoconferencing capabilities.  The patients’ existing primary care physicians were 
contacted when a case managed determined that a change in patient management was 
indicated.   The intervention group had a statistically significant decrease in HbA1c 
relative to usual care (P = 0.001), but the decrease was not deemed to be clinically 
significant.  Unfortunately, no Medicare cost savings were observed (Moreno et al., 
2008) 
Other Internet-based systems for the management of patients with poorly 
controlled type 2 diabetes showed more favorable results.  In one (McMahon et al., 
2005), all patients attended a half-day diabetes educational meeting, and the 
interventional group patients met with a team of educators consisting of a pharmacist, a 
nurse, and a nutritionist. This group also received an electronic notebook, and a system 
for the home monitoring of their blood glucose.  They had access to a secure website 
from which data from the monitoring system could be viewed (by both patients and 
caregivers), and provided diabetes educational modules, and the capability for patients to 
communicate with caregivers.  A statistically significant reduction in HbA1c was 
achieved in both groups (P < 0.001) at 3, 6, 9 and 12 months from baseline, and was 
greater at 12 months in the interventional group compared with the control group (P < 
0.05).  Unfortunately, results in a more recent study (Fonda et al., 2009) were not 
impressive.  Fonda et al. (2009) used a small sample (52 each in experimental and control 
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groups) where the experimental group received a notebook computer, a glucose meter, 
training in the use of these devices, toll-free dial-up Internet service, and secure access to 
the  study website.  Subjects interacted with the study’s advanced practice nurse (a 
certified diabetes educator) both via the internal messaging system of the computer and 
occasionally through telephone contact.  The Web site accepted electronic transmissions 
from the glucose monitoring devices and displayed these data in graphic and tabular form 
for both the subject and the nurse to review.   Subjects could send and receive secure 
messages to and from the care manager.  Web-enabled diabetes educational modules and 
links to other Web-based diabetes resources were provided.  After 12 months, decreases 
in HbA1c in the experimental group, although observed, were not statistically significant 
(P = 0.25). 
 Recently, an Internet-based patient monitoring system which involves no active 
clinician input has been noted (Lim et al., 1022), relying instead on a “rule engine” based 
on the clinical guidelines of the American and Korean Diabetes Associations.  Patients 
were send weekly directions based upon their weekly and monthly blood glucose and 
HbA1c levels.  The mean HbA1c and fasting blood glucose levels during the study 
decreased significantly in experimental group compared with the control group (P = 
0.007).  Because this system allows patients to make self-adjustments to their treatment 
based on automatic algorithms, it enhances patient empowerment in diabetes care. 
The preponderance of evidence seems to support the use of mobile telephones 
combined with web-based electronic communications for better control of blood glucose 
for type 2 diabetics.  Based upon a meta-analysis of English-language articles published 
between January 2002 and March 2012, (Liu and Ogwu, 2012, 17) concluded that 
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“overall, significant improvements were observed in blood glucose and/or HbA1c 
concentration” when mobile telephone interventions and mobile telephones were used. 
Results 
The effect of patients using blood glucose monitors alone has shown to have little 
improvement of diabetes health, but does improve patient education of overall health and 
what factors may be necessary for successful improvements. As new technologies have 
been developed in the self-management of diabetes, these devices can help to achieve and 
maintain blood glucose targets by improving the overall capability of monitoring glucose 
levels (Boyle, 2008).  
Telemedicine shows great promise in the monitoring and treatment of diabetes 
patients (Brown, et al., 2007; Franc et al, 2011).  Telemedicine allows the physician to 
monitor a patient via the web, without having to make a trip to the doctor’s office. The 
total cost of these monitoring systems can be quite variable, ranging from five dollars per 
patient to $6,340 (Jackson et al., 2006). 
Results for effectiveness of diabetes technology varied with the different 
comparisons of monitoring systems and technological preventative tools; improvements 
in HbA1c were often significant, albeit relatively small.   
Discussion 
This study reviewed new technological approaches to the monitoring and control 
of blood glucose. The results demonstrated that using technologies such as cell phones, 
wireless blood glucose monitoring devices, and the internet to monitor blood glucose 
may be beneficial to both the patient and the physician. The patients benefit from these 
technologies was by allowing for continuous and real time monitoring of their blood 
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glucose levels. Physicians benefited by improving the quality and productivity of their 
care giving.  New technologies have been demonstrated to have had a positive effect on 
diabetes monitoring, and new applications continue to be developed.   
The Ford Motor Co. and Medtronic have developed a blood glucose monitoring 
system that can be worn by the driver or passenger, and monitors the blood glucose levels 
of the person by using Bluetooth technology to link up to the very popular Sync system 
developed by Microsoft which is installed in many Ford vehicles.  The program can place 
glucose levels, signs and symptoms of confusion, blurry vision and lightheadedness for 
passengers wearing the device when levels become too low alerting one to take proper 
action at the appropriate time reducing the risk hypoglycemia and dangerous risk factors 
for driving.  Ford has even recently released a prototype automobile app featuring both a 
Bluetooth-enabled in-dash continuous glucose monitoring device and a voice controlled 
cellphone-based diabetes monitoring service which could potentially decrease risks, 
accidents or deaths (Tenderich, 2011).   
Current systems for continuous glucose monitoring (CGM) are the result of 
progressive technological improvement, and beneficial effects on glucose control have 
increasingly been demonstrated.  Developing and as yet unknown technologies should 
only be more exciting and potentially effective in patients’ contribution to diabetes self-
management in the future.   
Conclusions 
The utilization of current and future HIT have been shown to have a positive 
effect on both type 1 and type 2 diabetes monitoring.  Specifically, smartphones and 
telemedicine have also been shown to be effective in blood glucose monitoring. 
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